Latest Meningitis Vaccine now available for International Student travelers from India to US

MUMBAI, India - July 11, 2013 - PRLog -- Latest Meningoccal Meningitis Vaccine now available for International Student travelers from India to US, Australia, UK etc.

Meningitis is a serious life threatening disease that can affect cause high fever, seizures, vomiting and a very rapid death if not diagnosed & treated in time. People staying in close quarters (like students in hostels) are at a higher risk for this disease. Hence when a student travels for higher studies internationally to USA, Australia, New Zealand, UK or any other country, many Universities insist that the student should take the Meningococcal Vaccine. TravelSafe Clinic, India now offers the latest MCV4 vaccine (Menactra) at all its centers in Chandigarh, Delhi & Mumbai.

More about the disease & the vaccine:

The meningococcal disease can be prevented by the following vaccines: MCV4 and MPSV4.

Who should get the vaccine?

All adolescents and young adults should receive this vaccine as prevention.

When should the vaccine be given to my child?

11-12 years of age: One shot now and a booster dose to be given at 16 years of age.
13-15 years of age: One shot now and a booster dose to be given between 16-18 years of age.
> 16 years of age: Only a single shot is recommended and no booster. This is especially important for newly enrolled students who will be joining educational institutions in India and abroad and will be living in dorms or other closed housing.

It is a compulsory vaccination in the immunization schedule in the US but recommended only for high risk groups in India like students, people travelling abroad, people with medical conditions like having the spleen removed etc.

Where can I get this vaccine?
This vaccine is freely available. Please contact your healthcare provider. Travelsafe clinic (http://travelsafeclinic.com/contact-us/) has this vaccine in stock all the time. Please contact us (http://travelsafeclinic.com/contact-us/) for a free consultation.
Is the vaccine safe?
Yes, this is an imported vaccine that is safely used around the world in most developed countries including USA. Most people taking this vaccine will not have any side-effects whatsoever. However, a vaccine, like any medicine, is capable of causing serious problems such as severe allergic reactions. The risks associated with the vaccine are much less significant that the risks if one should contract meningococcal disease.

Mild reactions:

About half of people who receive the shot have mild redness and soreness at the site of injection and this usually gets better within 1-2 days. Only a very small percentage of people develop fever.

Severe reactions:

Allergic reactions like hives, breathing difficulties occur only in the rarest of rare cases and the center where you receive the vaccine will have facilities to provide emergency treatment prior to shifting to hospital in the extremely unlikely event that this should happen.

About Us
TravelSafe Clinic is India’s first certified, branded & authoritative multi-city travel health clinic. Our Aim is to create a World Class, state of the art travel health clinic, providing up-to-date advice to make International travel safe and healthy while avoiding common preventable diseases. We have trained physicians and paramedical staff to help deal with all your travel health questions. TravelSafe clinics are located in Mohali (Chandigarh), Noida (National Capital Region, Delhi) & Mumbai. We are the only travel clinic to be members of all the elite professional travel health organizations in the world including International Society for Travel Medicine (ISTM (http://www.istm.org/)), American Society of Tropical Medicine & Hygiene (ASTMH (http://www.astmh.org/)), International Association for Medical Assistance to Travelers (IAMAT (http://www.iamat.org/)), and British & Global Travel Health Association (BGTHA (http://www.bgtha.org/)) . We are also the only organization from India to have presented data on the safety & tolerability of Stamaril (Yellow Fever Vaccine) in Indian population at various International conferences.